{"id":"https://openalex.org/W2246734286","doi":null,"title":"Combination effect of TZT-1027 (Soblidotin) with other anticancer drugs.","display_name":"Combination effect of TZT-1027 (Soblidotin) with other anticancer drugs.","publication_year":2006,"publication_date":"2006-03-01","ids":{"openalex":"https://openalex.org/W2246734286","mag":"2246734286","pmid":"https://pubmed.ncbi.nlm.nih.gov/16619516"},"language":"en","primary_location":{"id":"pmid:16619516","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16619516","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067947584","display_name":"Tsugitaka Natsume","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090259","display_name":"ASKA Pharmaceutical (Japan)","ror":"https://ror.org/0097kbr85","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210090259"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tsugitaka Natsume","raw_affiliation_strings":["ASKA Pharmaceutical Co., Ltd., R&D Administration, Kawasaki-shi, Kanagawa 213-8522, Japan. natsume-t@aska-pharma.co.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ASKA Pharmaceutical Co., Ltd., R&D Administration, Kawasaki-shi, Kanagawa 213-8522, Japan. natsume-t@aska-pharma.co.jp","institution_ids":["https://openalex.org/I4210090259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069847628","display_name":"Junichi Watanabe","orcid":"https://orcid.org/0000-0003-2713-8985","observed_orcids":["https://orcid.org/0000-0003-2713-8985"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jun-Ichi Watanabe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113774767","display_name":"T. Horiuchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshi Horiuchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5069774952","display_name":"Motohiro Kobayashi","orcid":"https://orcid.org/0000-0002-7607-0801","observed_orcids":["https://orcid.org/0000-0002-7607-0801"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Motohiro Kobayashi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9366,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.76853234,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"26","issue":"2A","first_page":"1145","last_page":"51"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.8192999958992004,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.8192999958992004,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.1225999966263771,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.012400000356137753,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/microtubule-inhibitors","display_name":"microtubule inhibitors","score":0.8309999704360962},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8299999833106995},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.5809999704360962},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9399999976158142},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":1.0},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9959999918937683},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.875},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9570000171661377},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.972000002861023},{"id":"https://openalex.org/keywords/a549-lung-cancer","display_name":"A549 lung cancer","score":0.8209999799728394},{"id":"https://openalex.org/keywords/sequential-administration","display_name":"sequential administration","score":0.6230000257492065},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.8659999966621399}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.833584725856781},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7595834732055664},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5981419086456299},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.585839033126831},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.5597871541976929},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5354092121124268},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.48055508732795715},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.4798676371574402},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.43826204538345337},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4270452857017517},{"id":"https://openalex.org/C3019864225","wikidata":"https://www.wikidata.org/wiki/Q5867482","display_name":"Combination chemotherapy","level":3,"score":0.4238329529762268},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4225677251815796},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3534129559993744},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24655339121818542},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09395265579223633},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007941","descriptor_name":"Leukemia P388","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:16619516","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16619516","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:2246734286","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16619516","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2503161539","https://openalex.org/W2187103161","https://openalex.org/W2612528305","https://openalex.org/W2413830929","https://openalex.org/W2002913405","https://openalex.org/W1981558181","https://openalex.org/W2048944062","https://openalex.org/W2915023540","https://openalex.org/W2080894002","https://openalex.org/W2144320251"],"abstract_inverted_index":{"BACKGROUND:":[0],"TZT-1027":[1,32,40,131,155,196],"(Soblidotin),":[2],"an":[3],"antimicrotubule":[4],"drug,":[5],"has":[6,16],"shown":[7],"potent":[8,182],"antitumor":[9,13,53,183,199],"efficacy":[10],"in":[11,33,51,126,139,163,204],"various":[12],"models,":[14,54],"and":[15,62,75,87,105,110,117,137,146,161,197],"entered":[17],"into":[18],"phase":[19],"I":[20],"clinical":[21,34,205],"trials.":[22],"To":[23],"determine":[24],"those":[25],"anticancer":[26,43],"drugs":[27,44,112,200],"to":[28,92],"be":[29,93,202],"combined":[30,94,111,133,157,174],"with":[31,41,95,134,158],"trials,":[35],"the":[36,55,63,98,140,164,173,180],"combination":[37,101,193],"effects":[38],"of":[39,100,150,195],"other":[42],"were":[45,73,90,120],"examined.":[46],"MATERIALS":[47],"AND":[48],"METHODS:":[49],"Two":[50],"vivo":[52],"murine":[56],"P388":[57,141],"leukemia":[58],"ascites":[59,143],"tumor":[60,71,144,167],"model":[61],"human":[64],"non-small":[65],"cell":[66,142],"lung":[67],"cancer":[68],"A549":[69,165],"solid":[70,166,208],"model,":[72,145],"used":[74],"cisplatin":[76],"(CDDP),":[77],"gemcitabine":[78],"(GEM),":[79],"irinotecan":[80],"hydrochloride":[81],"(CPT-11),":[82],"fluorouracil":[83],"(5-FU),":[84],"paclitaxel":[85],"(PTX)":[86],"docetaxel":[88],"(DTX)":[89],"selected":[91],"TZT-1027.":[96],"Regarding":[97],"schedule":[99],"administration,":[102,170],"simultaneous":[103],"administration":[104,107],"sequential":[106],"(TZT-1027":[108],"first":[109],"administered":[113,177],"24":[114],"h":[115],"later,":[116],"vice":[118],"versa)":[119],"employed.":[121],"RESULTS:":[122],"A":[123],"significant":[124,148,192],"increase":[125],"lifespan":[127],"was":[128,132,152,156,176],"observed":[129,153],"when":[130,154,172],"CDDP,":[135,159],"GEM":[136,160],"CPT-11":[138],"a":[147,191],"inhibition":[149],"growth":[151],"DTX":[162],"model.":[168],"Sequential":[169],"particularly":[171],"drug":[175],"first,":[178],"showed":[179],"most":[181],"efficacy.":[184],"CONCLUSION:":[185],"These":[186],"findings":[187],"strongly":[188],"suggest":[189],"that":[190],"effect":[194],"these":[198],"can":[201],"expected":[203],"trials":[206],"for":[207],"tumors.":[209]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}